Abstract
Purpose
Haemorrhagic cystitis (HC) after allogeneic transplantation (HSCT) is a condition characterized by diffuse inflammation and bleeding from the bladder mucosa. Treatment of HC is not standardized and clinical Guidelines are elusive. The aim of this study was to evaluate the safety and efficacy of intravesical treatment with platelet-rich plasma (PRP) in patients with HC after allogenic HSCT.
Methods
Data from ten consecutive patients with BK virus-induced HC between 2013 and 2017 were collected. HC was classified into four grades. Inclusion criteria were (a) grade 3 or 4 BKV-induced HC after allogenic HSCT; (b) HC refractory to conservative therapy. All patients underwent transurethral cystoscopy and PRP treatment under general anaesthesia.
Results
Mean patients’ age was 33.6 years. Four patients (40%) presented a grade 3 BKV-induced HC and six patients (60%) a grade 4. No intraoperative complications occurred. Postoperative complications were recorded in six patients: three patients required blood transfusion while three patients endovenous antibiotic therapy. Median time to catheter removal was 6 days (IQR 2–10). Median length of hospitalization was 35 days (IQR 6–73). At 30 days after surgery, a three-way catheter was repositioned in one patient for grade 4 haematuria, six patients had a complete response, and three a partial response.
Conclusions
Our preliminary experience suggests that intravesical administration of PRP should be considered as a feasible and safe option for the treatment of BK-induced HC after HSCT. Future studies are needed to assess its potential value in other forms of haemorrhagic cystitis.
Similar content being viewed by others
References
Diniz S, Dinis P, Cruz F et al (2013) Bladder pain syndrome/interstitial cystitis: present and future treatment perspectives. Minerva Urol Nefrol 65(4):263–276
Sosnowski R, Kulpa M, Kosowicz M et al (2017) Basic methods for the assessment of health-related quality of life in uro-oncological patients. Minerva Urol Nefrol 69(5):409–420. https://doi.org/10.23736/s0393-2249.16.02726-0
Katmawi-Sabbagh S, Hussain T, Al-Sudani M et al (2010) The role of the one stop hematuria clinic in reducing time to diagnosis and treatment of urological cancers. Minerva Urol e Nefrol Italian J Urol Nephrol 62:331–332
Peinemann F, de Villiers EM, Dorries K et al (2000) Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr 159(3):182–188
Gorczynska E, Turkiewicz D, Rybka K et al (2005) Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl 11(10):797–804. https://doi.org/10.1016/j.bbmt.2005.06.007
Hofland CA, Eron LJ, Washecka RM (2004) Hemorrhagic adenovirus cystitis after renal transplantation. Transpl Proc 36(10):3025–3027. https://doi.org/10.1016/j.transproceed.2004.10.090
Svahn B-M, Alvin O, Ringden O et al (2006) Costs of allogeneic hematopoietic stem cell transplantation. Transplantation 82(2):147–153. https://doi.org/10.1097/01.tp.0000226171.43943.d3
Cesaro S, Dalianis T, Hanssen Rinaldo C et al (2018) ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother 73(1):12–21. https://doi.org/10.1093/jac/dkx324
Harkensee C, Vasdev N, Gennery AR et al (2008) Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation–a systematic review and evidence-based guidance for clinical management. Br J Haematol 142(5):717–731. https://doi.org/10.1111/j.1365-2141.2008.07254.x
Choong SK, Walkden M, Kirby R (2000) The management of intractable haematuria. BJU Int 86(9):951–959. https://doi.org/10.1016/j.urology.2019.01.003
Abt D, Bywater M, Engeler DS et al (2013) Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol 20(7):651–660. https://doi.org/10.1111/iju.12113
Tirindelli MC, Flammia GP, Bove P et al (2014) Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 20(10):1612–1617. https://doi.org/10.1016/j.bbmt.2014.06.018
Purves JT, Graham ML, Ramakumar S (2005) Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology 66(3):641–643. https://doi.org/10.1016/j.urology.2005.03.037
Martinez-Martinez A, Ruiz-Santiago F, Garcia-Espinosa J (2018) Platelet-rich plasma: myth or reality? Radiologia 60(6):465–475. https://doi.org/10.1016/j.urology.2005.03.037
Alomari EB, Sultan K (2019) Efficacy of injectable platelet-rich plasma in reducing alveolar bone resorption following rapid maxillary expansion: a cone-beam computed tomography assessment in a randomized split-mouth controlled trial. Angle Orthod. https://doi.org/10.2319/091018-661.1
Hurley ET, Maye AB, Mullett H (2019) Arthroscopic rotator cuff repair: a systematic review of overlapping meta-analyses. JBJS Rev. https://doi.org/10.2106/jbjs.rvw.18.00027
Griffin MF, Naderi N, Kalaskar DM et al (2019) Argon plasma surface modification promotes the therapeutic angiogenesis and tissue formation of tissue-engineered scaffolds in vivo by adipose-derived stem cells. Stem Cell Res Ther. 10(1):110. https://doi.org/10.1186/s13287-019-1195-z
da Pereira FRC, De La Corte FD, Brass KE et al (2019) Evaluation of three methods of platelet-rich plasma for treatment of equine distal limb skin wounds. J equine Vet Sci 72:1–7. https://doi.org/10.1016/j.jevs.2017.10.009
Leung AYH, Mak R, Lie AKW et al (2002) Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transpl 29(6):509–513. https://doi.org/10.1038/sj.bmt.1703415
Katayama H, Kurokawa Y, Nakamura K et al (2016) Extended Clavien-Dindo classification of surgical complications: Japan clinical oncology group postoperative complications criteria. Surg Today 46(6):668–685. https://doi.org/10.1007/s00595-015-1236-x
Victal ML, D’Ancona CA, Junqueira RG et al (2015) Test-retest reliability and discriminant validity for the Brazilian version of “The interstitial cystitis symptom index and problem index” and “pelvic pain and urgency/Frequency (PUF) patient symptom scale” instruments. Transl Androl Urol 4(6):594–599. https://doi.org/10.3978/j.issn.2223-4683.2015.11.01
Norkin M, Wingard JR (2017) Recent advances in hematopoietic stem cell transplantation. F1000 Res 6:870. https://doi.org/10.12688/f1000research.11233.1
Cesaro S, Pillon M, Tridello G et al (2013) Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European group for Blood and Marrow transplantation. Bone Marrow Transpl 48(6):809–813. https://doi.org/10.1038/bmt.2012.247
Dalianis T, Hirsch HH (2013) Human polyomaviruses in disease and cancer. Virology 437(2):63–72. https://doi.org/10.1016/j.virol.2012.12.015
Mackey MC (2012) Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother 46(3):442–446. https://doi.org/10.1345/aph.1q430
Cesaro S, Brugiolo A, Faraci M et al (2003) Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transpl 32(9):925–931. https://doi.org/10.1038/sj.bmt.1704252
Tang FF, Zhang XH, Chen H (2017) Surgical treatment of severe, refractory hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation: a report of 17 patients. Zhonghua Nei Ke Za Zhi 1(56):414–418. https://doi.org/10.3760/cma.j.issn.0578-1426.2017.06.006
Bennett NT, Schultz GS (1993) Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165(6):728–737. https://doi.org/10.1016/s0002-9610(05)80797-4
Donmez MI, Inci K, Zeybek ND et al (2016) The early histological effects of intravesical instillation of platelet-rich plasma in cystitis models. Int Neurourol J 20(3):188–196. https://doi.org/10.5213/inj.1632548.274
Jhang J-F, Wu S-Y, Lin T-Y et al (2017) Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. Low Urin Tract Symptoms 10:11. https://doi.org/10.1111/luts.12212
Acknowledgements
No financial support has been received for this research/study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors deny any potential conflicts of interest. All authors have no direct or indirect commercial financial incentive or interest associated with publishing the article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Masieri, L., Sessa, F., Mari, A. et al. Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience. Int Urol Nephrol 51, 1715–1720 (2019). https://doi.org/10.1007/s11255-019-02223-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-019-02223-0